 TUSTIN, Calif., Dec. 01, 2020 GLOBE NEWSWIRE -- Avid Bioservices, Inc. NASDAQ:CDMO NASDAQ:CDMOP, a dedicated biologics contract development and manufacturing organization CDMO working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that its Board of Directors has declared a quarterly cash dividend payment on the Companys 10.50 Series E Convertible Preferred Stock the Series E Preferred Stock. 